E Hope Weissler1, Dennis I Narcisse2, Jennifer A Rymer2, Ehrin J Armstrong3, Eric Secemsky4, William A Gray5, Jihad A Mustapha6, George L Adams7, Gary M Ansel8, Manesh R Patel2, W Schuyler Jones2. 1. Division of Vascular and Endovascular Surgery, 3065Duke University Health System, Durham, NC, USA. 2. Division of Cardiology, 3065Duke University Health System, Durham, NC, USA. 3. Division of Cardiology, University of Colorado School of Medicine, Aurora, CO, USA. 4. Division of Cardiology, 1859Beth Israel Deaconess Medical Center, Boston, MA, USA. 5. Main Line Health, Lankenau Heart Institute, Wynnewood, PA, USA. 6. Advanced Cardiac & Vascular Centers for Amputation Prevention, Grand Rapids, MI, USA. 7. Division of Cardiology, UNC REX Healthcare-Raleigh, NC, USA. 8. OhioHealth, Columbus, OH, USA.
Abstract
PURPOSE: Patients with diabetes mellitus (DM) are known to be at higher risk for peripheral artery disease (PAD), amputations, and major adverse cardiovascular events, though it is unclear whether they are at any higher risk for repeat intervention. LIBERTY 360 offered an opportunity to study a real-world cohort of patients who underwent distal superficial femoral artery endovascular revascularizations. We aimed to describe patients with DM, their outcomes following peripheral vascular intervention, and the effect of DM on outcomes in the LIBERTY 360 cohort. METHODS: LIBERTY 360 is a prospective, multi-center, non-randomized, mono-industry funded observational study of patients undergoing endovascular revascularization. Outcomes included 30-day and 1-year all-cause mortality, major amputation, target vessel/lesion revascularization, and a composite of those events. A multivariable regression model including DM was constructed to examine the effect of DM on outcomes. Multivariable survival estimates were made using Cox proportional hazards models. RESULTS: A total of 1,204 patients were enrolled, of whom 727 had DM (60.4%). Patients with DM had significantly more comorbidities and a third required insulin for DM management. Patients with DM had more severe disease based on Rutherford classification at baseline. After adjusting for comorbidities and disease severity, DM patients had more frequent major amputations at 1 year (5.2% versus 1.2%; HR 2.71, 95%CI 1.05-6.98, p = 0.040). The 1-year rates of all-cause mortality and target vessel/lesion revascularization were not significantly higher for patients with DM. CONCLUSIONS: Diabetes mellitus was associated with increased major amputations at 1 year following endovascular revascularization after accounting for demographics, comorbidities, and PAD-related characteristics. Further research is needed to determine which aspects of PAD and DM are most strongly associated with poor outcomes following lower extremity revascularization.
PURPOSE: Patients with diabetes mellitus (DM) are known to be at higher risk for peripheral artery disease (PAD), amputations, and major adverse cardiovascular events, though it is unclear whether they are at any higher risk for repeat intervention. LIBERTY 360 offered an opportunity to study a real-world cohort of patients who underwent distal superficial femoral artery endovascular revascularizations. We aimed to describe patients with DM, their outcomes following peripheral vascular intervention, and the effect of DM on outcomes in the LIBERTY 360 cohort. METHODS: LIBERTY 360 is a prospective, multi-center, non-randomized, mono-industry funded observational study of patients undergoing endovascular revascularization. Outcomes included 30-day and 1-year all-cause mortality, major amputation, target vessel/lesion revascularization, and a composite of those events. A multivariable regression model including DM was constructed to examine the effect of DM on outcomes. Multivariable survival estimates were made using Cox proportional hazards models. RESULTS: A total of 1,204 patients were enrolled, of whom 727 had DM (60.4%). Patients with DM had significantly more comorbidities and a third required insulin for DM management. Patients with DM had more severe disease based on Rutherford classification at baseline. After adjusting for comorbidities and disease severity, DM patients had more frequent major amputations at 1 year (5.2% versus 1.2%; HR 2.71, 95%CI 1.05-6.98, p = 0.040). The 1-year rates of all-cause mortality and target vessel/lesion revascularization were not significantly higher for patients with DM. CONCLUSIONS: Diabetes mellitus was associated with increased major amputations at 1 year following endovascular revascularization after accounting for demographics, comorbidities, and PAD-related characteristics. Further research is needed to determine which aspects of PAD and DM are most strongly associated with poor outcomes following lower extremity revascularization.
Authors: Gagan D Singh; Ehrin J Armstrong; Stephen W Waldo; Bejan Alvandi; Ellen Brinza; Justin Hildebrand; Ezra A Amsterdam; Misty D Humphries; John R Laird Journal: Vasc Med Date: 2017-03-20 Impact factor: 3.239
Authors: Michael S Conte; Andrew W Bradbury; Philippe Kolh; John V White; Florian Dick; Robert Fitridge; Joseph L Mills; Jean-Baptiste Ricco; Kalkunte R Suresh; M Hassan Murad Journal: J Vasc Surg Date: 2019-05-28 Impact factor: 4.268
Authors: George L Adams; Jihad Mustapha; William Gray; Nick J Hargus; Brad J Martinsen; Gary Ansel; Michael R Jaff Journal: Am Heart J Date: 2015-12-30 Impact factor: 4.749
Authors: Jihad Mustapha; William Gray; Brad J Martinsen; Ryan W Bolduan; George L Adams; Gary Ansel; Michael R Jaff Journal: J Endovasc Ther Date: 2019-02-06 Impact factor: 3.487
Authors: E Hope Weissler; Robert M Clare; Yuliya Lokhnygina; John B Buse; Shaun G Goodman; Brian Katona; Nayyar Iqbal; Neha J Pagidipati; Naveed Sattar; Rury R Holman; Adrian F Hernandez; Robert J Mentz; Manesh R Patel; W Schuyler Jones Journal: Diabet Med Date: 2021-03-18 Impact factor: 4.213